QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Awaiting Patent for Promising DehydraTECH Transdermal CBD Application
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) continues to add numerous U.S. and Australian patents to its existing portfolio. Among these is the company’s recent filing for a new transdermal application of cannabidiol (CBD) that followed successful laboratory evaluation of DehydraTECH delivery results. An article discussing the company reads: "LXRP is a British Columbia-based, cannabis-focused food bioscience company, and it is a technology disrupter for edible cannabinoids. Its DehydraTECH technology aids in the body’s absorption of cannabinoids. ... The company’s most recent patent filing follows successful laboratory evaluation of DehydraTECH in the transdermal delivery of cannabidiol (CBD). Results showed an…